Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.300
+0.090 (4.07%)
At close: Jun 21, 2024, 4:00 PM
2.220
-0.080 (-3.48%)
After-hours: Jun 21, 2024, 7:19 PM EDT

Oramed Pharmaceuticals Statistics

Total Valuation

ORMP has a market cap or net worth of $93.45 million. The enterprise value is -$50.59 million.

Market Cap 93.45M
Enterprise Value -50.59M

Important Dates

The next estimated earnings date is Thursday, August 8, 2024, after market close.

Earnings Date Aug 8, 2024
Ex-Dividend Date n/a

Share Statistics

ORMP has 40.63 million shares outstanding. The number of shares has increased by 3.80% in one year.

Shares Outstanding 40.63M
Shares Change (YoY) +3.80%
Shares Change (QoQ) +0.09%
Owned by Insiders (%) 11.28%
Owned by Institutions (%) 14.05%
Float 36.80M

Valuation Ratios

The trailing PE ratio is 8.85.

PE Ratio 8.85
Forward PE n/a
PS Ratio 138.64
Forward PS 52.35
PB Ratio 0.56
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.28, with a Debt / Equity ratio of 0.20.

Current Ratio 5.28
Quick Ratio n/a
Debt / Equity 0.20
Debt / EBITDA 3.32
Debt / FCF n/a
Interest Coverage -11.13

Financial Efficiency

Return on equity (ROE) is 6.60% and return on invested capital (ROIC) is -6.79%.

Return on Equity (ROE) 6.60%
Return on Assets (ROA) 5.20%
Return on Capital (ROIC) -6.79%
Revenue Per Employee $51,846
Profits Per Employee $804,308
Employee Count 13
Asset Turnover 0.00
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -40.41% in the last 52 weeks. The beta is 1.79, so ORMP's price volatility has been higher than the market average.

Beta (1Y) 1.79
52-Week Price Change -40.41%
50-Day Moving Average 2.31
200-Day Moving Average 2.47
Relative Strength Index (RSI) 51.97
Average Volume (20 Days) 149,480

Short Selling Information

The latest short interest is 286,503, so 0.71% of the outstanding shares have been sold short.

Short Interest 286,503
Short Previous Month 304,603
Short % of Shares Out 0.71%
Short % of Float 0.78%
Short Ratio (days to cover) 3.36

Income Statement

In the last 12 months, ORMP had revenue of $674,000 and earned $10.46 million in profits. Earnings per share was $0.26.

Revenue 674,000
Gross Profit 674,000
Operating Income -13.52M
Pretax Income 10.46M
Net Income 10.46M
EBITDA 9.81M
EBIT 9.59M
Earnings Per Share (EPS) $0.26
Full Income Statement

Balance Sheet

The company has $176.59 million in cash and $32.56 million in debt, giving a net cash position of $144.03 million or $3.55 per share.

Cash & Cash Equivalents 176.59M
Total Debt 32.56M
Net Cash 144.03M
Net Cash Per Share $3.55
Equity / Book Value 166.64M
Book Value Per Share 4.10
Working Capital 143.54M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$6.22 million and capital expenditures -$57,000, giving a free cash flow of -$6.28 million.

Operating Cash Flow -6.22M
Capital Expenditures -57,000
Free Cash Flow -6.28M
FCF Per Share -$0.15
Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -2,006.38% and 1,551.34%.

Gross Margin 100.00%
Operating Margin -2,006.38%
Pretax Margin 1,551.34%
Profit Margin 1,551.34%
EBITDA Margin 1,455.34%
EBIT Margin 1,423.44%
FCF Margin -931.60%

Dividends & Yields

ORMP does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.80%
Shareholder Yield -3.80%
Earnings Yield 11.19%
FCF Yield -6.72%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 1
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on January 23, 2013. It was a reverse split with a ratio of 1:12.

Last Split Date Jan 23, 2013
Split Type Reverse
Split Ratio 1:12

Scores

ORMP has an Altman Z-Score of 1.41 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.41
Piotroski F-Score 3